Navigation Links
FDA Accepts Noven's NDA For An Investigational Nonhormonal Therapy For Menopausal Vasomotor Symptoms
Date:11/12/2012

MIAMI, FL and NEW YORK, NY, Nov. 12, 2012 /PRNewswire/ -- Noven Pharmaceuticals, Inc., a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., today announced that its New Drug Application (NDA) for low-dose mesylate salt of paroxetine (LDMP; 7.5 mg) for the treatment of moderate to severe vasomotor symptoms (hot flashes and night sweats) due to menopause has been accepted for filing by the U.S. Food and Drug Administration (FDA). 

The acceptance of the NDA reflects the FDA's determination that the application is sufficiently complete to permit a substantive review. The NDA has been assigned a Prescription Drug User Fee Act (PDUFA) action date of June 28, 2013, which represents the goal date for the FDA to complete its review of the NDA.

In addition, the FDA advised Noven that the NDA for LDMP will be discussed at a meeting of the FDA's Reproductive Health Drugs Advisory Committee tentatively scheduled for March 4, 2013. 

Low-dose mesylate salt of paroxetine (LDMP) is an investigational oral nonhormonal therapy using 7.5 mg of paroxetine mesylate that was specifically developed for the treatment of vasomotor symptoms due to menopause. Noven submitted the LDMP NDA in August 2012. 

About Noven

Noven Pharmaceuticals, Inc. is a specialty pharmaceutical company engaged in the research, development, manufacturing, marketing and sale of prescription pharmaceutical products. Noven is committed to developing and offering products and technologies that meaningfully benefit patients, its customers and its industry partners. Noven is a stand-alone operating subsidiary of Japan-based Hisamitsu Pharmaceutical Co., Inc., and serves as Hisamitsu's U.S. growth platform in prescription pharmaceuticals. For more information about Noven, visit www.noven.com. For information about Hisamitsu, visit www.hisamitsu.co.jp/english.


'/>"/>
SOURCE Noven Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Sanofi Pasteur Presents Pediatric Data on Investigational Quadrivalent Influenza Vaccine
2. Data from Study of Elderly Depressed Patients are Reported for Investigational Compound Lu AA21004 on Symptoms of Major Depressive Disorder (MDD)
3. Ambit Biosciences and Teva Announce Clearance of an Investigational New Drug (IND) Application for CEP-32496, A Novel BRAF(V600E) Inhibitor
4. Results of Phase II Study of Boehringer Ingelheims Investigational Bronchodilator for COPD Presented at 2012 ATS International Conference
5. Lilly Diabetes Presents Phase II Blood Pressure and Heart Rate Data on Investigational GLP-1 Analog Candidate, Dulaglutide, in Patients with Type 2 Diabetes at the 27th American Society of Hypertension Scientific Meeting
6. Lilly and Boehringer Ingelheim Present Data at the 72nd American Diabetes Association Scientific Sessions® from Phase II Studies Comparing Investigational Novel Basal Insulin to Insulin Glargine
7. Abbott Presents Results of Clinical Studies Evaluating Its Investigational Treatment for Advanced Parkinsons Disease
8. Results For Phase 2b Trial Of Unique Investigational Cell-Based Therapy In Venous Leg Ulcers Published In The Lancet
9. Janssen Biotech Announces Global License and Development Agreement for Investigational Anti-Cancer Agent Daratumumab
10. Clinical Study With Investigational Cream Aims To Help Women Who Experience Painful Sex
11. Omeros Files Investigational New Drug Application for Lead Compound in PDE10 Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... --  Millar, Inc. , a leader in catheter-based and ... of Craig Thummel , President/CEO and member of ... to the Company. The Company also announced its leadership ... Executive Management team as his successors. The Board of ... of Sales and Marketing, as President, and also a ...
(Date:6/30/2015)... VALLEY, Pa. , June 30, 2015 /PRNewswire/ ... and delivering innovative solutions for medical and surgical ... is guaranteeing next-day replacements for surgical equipment at ... product manufacturer to offer this type of guarantee. ... Olympus Full Service Agreement earlier this year. ...
(Date:6/30/2015)... FREMONT, Calif. , June 30, 2015  Ardelyx, ... focused on cardio-renal, gastrointestinal and metabolic diseases, today announced ... on July 14, 2015, from 8:00 a.m.- 1:00 pm ... The Ardelyx senior management team will ... its lead compound, tenapanor, which has completed Phase 2b ...
Breaking Medicine Technology:Millar, Inc. Announces Leadership Changes 2Millar, Inc. Announces Leadership Changes 3Olympus Introduces Industry-First Next-Day Product Replacement Guarantee for Surgical Business 2Olympus Introduces Industry-First Next-Day Product Replacement Guarantee for Surgical Business 3Ardelyx to Host Inaugural R&D Investor Day in New York City on July 14, 2015 2
... SAN DIEGO, Oct. 7 CareFusion Corporation (NYSE: CFN ) ... 2010 on Tuesday, Nov. 10 following the close of trading on ... webcast and conference call on Nov. 10 at 2:00 pm Pacific ... first quarter, ended on Sep. 30, 2009. To access the call ...
... October 7 DBMS Consulting announced that it,has successfully ... Oracle E-Business Suite (EBS) for SIRO Clinpharm, one of ... fully,automated capabilities in management of clinical trial process, clinical,trial ... After this implementation, SIRO gains complete operational ...
Cached Medicine Technology:CareFusion Will Host An Earnings Conference Call on November 10, 2009 to Discuss the Results for the First Quarter of Fiscal 2010 2DBMS Consulting Successfully Completes Roll out of Oracle Health Sciences Applications (OHSA) Suite for SIRO Clinpharm 2DBMS Consulting Successfully Completes Roll out of Oracle Health Sciences Applications (OHSA) Suite for SIRO Clinpharm 3
(Date:6/30/2015)... ... June 30, 2015 , ... The progress of ... multidistrict litigation now underway in the U.S. District Court, Eastern District of Louisiana, ... to the Court’s calendar, that conference has now been scheduled for July 9th, ...
(Date:6/30/2015)... ... 2015 , ... Dr. Sammy Masri of Masri Sports Medicine &Wellness, NJ Top ... diagnosis and treatment of non-surgical sports and other musculoskeletal injuries for both adults and ... and use exercise to stay healthy and active. Dr. Masri seeks to provide his ...
(Date:6/30/2015)... ... June 30, 2015 , ... ... and general manager of HRA Healthcare Research & Analytics , a consultative ... Hennessy Associates, Inc. (MJH) family of businesses. HRA offers quantitative and qualitative, custom ...
(Date:6/30/2015)... ... 30, 2015 , ... America’s oldest cancer center and one ... prevention, screening and care for the people of Nigeria. Roswell Park Cancer Institute ... Roswell Park faculty providing clinical consultations to assist LCC oncologists, who will also ...
(Date:6/30/2015)... ... June 30, 2015 , ... New Energy Works Timberframers ... 7th and 11th 2015. Timber frame post and beam raisings offer a chance to ... a timber frame is an important and exciting event – it is ...
Breaking Medicine News(10 mins):Health News:Progress of Federal Xarelto Lawsuits Pending in Multidistrict Litigation to Be Discussed During July 9th Status Conference 2Health News:Progress of Federal Xarelto Lawsuits Pending in Multidistrict Litigation to Be Discussed During July 9th Status Conference 3Health News:NJ Top Docs Presents Dr. Sammy Masri; Dr. Masri is Now Offering a Wide Range of Services to his Valued Patients 2Health News:NJ Top Docs Presents Dr. Sammy Masri; Dr. Masri is Now Offering a Wide Range of Services to his Valued Patients 3Health News:NJ Top Docs Presents Dr. Sammy Masri; Dr. Masri is Now Offering a Wide Range of Services to his Valued Patients 4Health News:NJ Top Docs Presents Dr. Sammy Masri; Dr. Masri is Now Offering a Wide Range of Services to his Valued Patients 5Health News:HRA Healthcare Research & Analytics Welcomes 'Creative Problem Solver' as New Executive Vice President 2Health News:HRA Healthcare Research & Analytics Welcomes 'Creative Problem Solver' as New Executive Vice President 3Health News:Intercontinental Oncology Partnership Brings Access to Specialized Cancer Care to Nigeria 2Health News:Intercontinental Oncology Partnership Brings Access to Specialized Cancer Care to Nigeria 3Health News:Intercontinental Oncology Partnership Brings Access to Specialized Cancer Care to Nigeria 4Health News:Intercontinental Oncology Partnership Brings Access to Specialized Cancer Care to Nigeria 5Health News:Join New Energy Works Timberframers in Raising the Frames in Western New York 2Health News:Join New Energy Works Timberframers in Raising the Frames in Western New York 3Health News:Join New Energy Works Timberframers in Raising the Frames in Western New York 4
... from the Society for Cardiothoracic Surgery in Great Britain ... the first time recorded the variations in activity and ... Kingdom and Ireland. Presented at the recent Annual Meeting ... & Ireland (Edinburgh, Scotland), The First National Thoracic Database ...
... LeadCheck(R) Swabs Warns Parents After Survey Finds Contaminated ... ... The makers of LeadCheck(R),Swabs, the leading consumer lead detection kit, today warned ... survey that found nearly 30 percent of holiday toys,purchased randomly at retail ...
... a significant human pathogen, infecting more than three percent ... the United States has been estimated to be as ... of the journal PLoS Pathogens, Timothy Tellinghuisen, an assistant ... and his colleagues describe how they used mutations of ...
... to better understanding of the incurable neurological disorder , , ... gene called GIGYF2 may be directly linked to the ... of the neurodegenerative condition, U.S. researchers report. , "These ... development of new therapeutic -- and possibly even preventive ...
... MEDai, Inc., headquartered in,Orlando, FL, a leading provider ... analytics, has been helping health plans,and providers across ... the upcoming World Research Group Predictive Modeling Optimization,Conference ... session and,workshop that helps organizations focus on how ...
... Already Slated for 2009 & 2010 Will Top 20% ... ... Jobs, WASHINGTON, March 20 Leaders in the home,oxygen community ... about projected program reductions,tied to Medicare,s competitive bidding program for the ...
Cached Medicine News:Health News:New report highlights variations in approaches to thoracic surgery in the United Kingdom and Ireland 2Health News:New report highlights variations in approaches to thoracic surgery in the United Kingdom and Ireland 3Health News:New report highlights variations in approaches to thoracic surgery in the United Kingdom and Ireland 4Health News:Scripps Florida scientists develop a process to disrupt hepatitis C virion production 2Health News:Scripps Florida scientists develop a process to disrupt hepatitis C virion production 3Health News:Gene Linked to Form of Parkinson's Disease 2Health News:MEDai Assists Healthcare Organizations Demonstrate the Value of Predictive Modeling 2Health News:Home Oxygen Leaders Warn That Competitive Bidding Program Reductions Combined with Other Pending and Proposed Cuts Are 'Unsustainable and Unpredictable' 2
Six inch wide elastic belt transfers the apron weight off the shoulders. 0.5mm front and 0.25mm back with a generous overlap for double protection. Shoulder pads included. Also available without wide...
Front protection with choice of adjustable 2" buckle or velcro belt which crosses the back for a comfortable fit. Adjustable straps at shoulders keeps apron snug....
... Versatile, pocket-size peripheral ... either a full-function nerve ... block monitor, depending upon ... is attached. Includes NSL-5 ...
Low pressure automatic tourniquet with manual time. Includes extension hose and spiral replacement hose....
Medicine Products: